Correlation between serum C1q-adiponectin/total adiponectin ratio and polyvascular lesions detected by vascular ultrasonography in Japanese type 2 diabetics

Metabolism: Clinical and Experimental

Volumn 62, Issue 3, 2013, Pages 376-385

  Hirata, Ayumu ^a   Kishida, Ken ^a   Kobayashi, Hironori ^b   Nakatsuji, Hideaki ^a   Funahashi, Tohru ^a,c   Shimomura, Iichiro ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OTSUKA PHARMACEUTICAL CO LTD   (Japan)

^c OSAKA UNIVERSITY   (Japan)

Author keywords

Adiponectin; C1q; C1q binding adiponectin, polyvascular atherosclerosis; Vascular ultrasonography

Indexed keywords

ADIPONECTIN; COMPLEMENT COMPONENT C1Q;

ADULT; AGED; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; DIABETIC PATIENT; ECHOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INTRAABDOMINAL FAT; JAPANESE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POLYVASCULAR ATHEROSCLEROSIS; PRIORITY JOURNAL; VASCULAR ULTRASONOGRAPHY;

ADIPONECTIN; ADULT; AGED; AGED, 80 AND OVER; ARTERIES; ATHEROSCLEROSIS; C-REACTIVE PROTEIN; COMPLEMENT C1Q; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INTERLEUKIN-6; INTRA-ABDOMINAL FAT; JAPAN; MALE; MIDDLE AGED; ROC CURVE; STATISTICS, NONPARAMETRIC; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 84874118493     PISSN: 00260495     EISSN: 15328600     Source Type: Journal    
DOI: 10.1016/j.metabol.2012.08.009     Document Type: Article

References (27)

1. S. Yakubov Polyvascular atherosclerotic disease: recognizing the risks and managing the syndrome Curr Med Res Opin 25 2009 2631 2641
2. C. Suárez, U. Zeymer, and T. Limbourg REACH Registry Investigators. Influence of polyvascular disease on cardiovascular event rates. Insights from the REACH Registry Vasc Med 15 2010 259 265
3. M. Dilic, A. Dzubur, and Z. Kusljugic Correlation of arterial hypertension and type 2 diabetes mellitus with type of polyvascular atherosclerotic disease Med Arh 64 2010 264 268
4. A. Hirata, K. Kishida, and H. Nakatsuji Metabolic syndrome correlates with polyvascular lesions detected by systemic vascular ultrasonography in Japanese people with type 2 diabetes Diabetes Res Clin Pract 96 2012 e26 e29
5. A. Hirata, K. Kishida, and A. Hiuge-Shimizu Qualitative score of systemic arteriosclerosis by vascular ultrasonography as a predictor of coronary artery disease in type 2 diabetes Atherosclerosis 219 2011 623 629
6. C. Herder, M. Karakas, and W. Koenig Biomarkers for the prediction of type 2 diabetes and cardiovascular disease Clin Pharmacol Ther 90 2011 52 66
7. Y. Arita, S. Kihara, and N. Ouchi Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity Biochem Biophys Res Commun 257 1999 79 83
8. R. Shibata, N. Ouchi, and T. Murohara Adiponectin and cardiovascular disease Circ J 73 2009 608 614
9. K. Kishida, T. Funahashi, and I. Shimomura Molecular mechanisms of diabetes and atherosclerosis: role of adiponectin Endocr Metab Immune Disord Drug Targets 12 2012 118 131
10. H. Nakatsuji, H. Kobayashi, and K. Kishida Binding of adiponectin and C1q in human serum, and clinical significance of the measurement of C1q-adiponectin / total adiponectin ratio Metabolism 2012 1 12
11. H. Nakatsuji, K. Kishida, T. Funahashi, I. Shimomura Senri Study II Group Three-month treatment with pioglitazone reduces circulating levels of thiobarbituric acid-reacting substances, a marker of reactive oxidative stress, without change in body mass index, in Japanese patients with type 2 diabetes Atherosclerosis 212 2010 243 245
12. C. Zoccali, F. Mallamaci, and G. Tripepi Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease J Am Soc Nephrol 13 2002 134 141
13. M. Ryo, K. Maeda, and T. Onda A new simple method for the measurement of visceral fat accumulation by bioelectrical impedance Diabetes Care 28 2005 451 453
14. N. Komura, S. Kihara, M. Sonoda Osaka CAD Group Clinical significance of high-molecular weight form of adiponectin in male patients with coronary artery disease Circ J 72 2008 23 28
15. S. Matsuo, E. Imai, M. Horio Collaborators developing the Japanese equation for estimated GFR Revised equations for estimated GFR from serum creatinine in Japan Am J Kidney Dis 53 2009 982 992
16. H. Nishizawa, I. Shimomura, and K. Kishida Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein Diabetes 51 2002 2734 2741
17. Y. Okauchi, K. Kishida, and T. Funahashi Changes in serum adiponectin concentrations correlate with changes in BMI, waist circumference, and estimated visceral fat area in middle-aged general population Diabetes Care 32 2009 e122
18. C. Weber, and H. Noels Atherosclerosis: current pathogenesis and therapeutic options Nat Med 17 2011 1410 1422
19. G.K. Hansson, and A. Hermansson The immune system in atherosclerosis Nat Immunol 12 2011 204 212
20. D.O. Haskard, J.J. Boyle, and J.C. Mason The role of complement in atherosclerosis Curr Opin Lipidol 19 2008 478 482
21. F. Niculescu, and H. Rus The role of complement activation in atherosclerosis Immunol Res 30 2004 73 80
22. U. Kishore, and K.B. Reid C1q: structure, function, and receptors Immunopharmacology 49 2000 159 170
23. M. Kojouharova, K. Reid, and M. Gadjeva New insights into the molecular mechanisms of classical complement activation Mol Immunol 47 2010 2154 2160
24. A.T. Naito, T. Sumida, and S. Nomura Complement c1q activates canonical wnt signaling and promotes aging-related phenotypes Cell 149 2012 1298 1313
25. S.E. Ross, N. Hemati, and K.A. Longo Inhibition of adipogenesis by Wnt signaling Science 289 2000 950 953
26. Y. Okamoto, Y. Arita, and M. Nishida An adipocyte-derived plasma protein, adiponectin, adheres to injured vascular walls Horm Metab Res 32 2000 47 50
27. K. Ebina, K. Oshima, and M. Matsuda Adenovirus-mediated gene transfer of adiponectin reduces the severity of collagen-induced arthritis in mice Biochem Biophys Res Commun 378 2009 186 191